Quidel completed the acquisition of Ortho Clinical Diagnostics for $8bn.

Quidel, a manufacturer of diagnostic healthcare products, completed the acquisition of Ortho Clinical Diagnostics, an in vitro diagnostics company, for $8bn. “We are very excited to bring together the talented and experienced teams of both Quidel and Ortho who share a commitment to the employees, customers, patients, and the communities we serve. We look forward to executing on our growth strategy as QuidelOrtho and enhancing care across the testing continuum while driving long-term value creation for our stockholders," Douglas Bryant, QuidelOrtho Chairman and CEO.